Gualberto Ruaño, M.D., Ph.D., Founder and Medical Director. Dr. Ruaño has been an innovator in the biotechnology industry for 25 years, and is a pioneer in the science and clinical deployment of personalized medicine. His continued record of scholarship and innovation in translational genomics and clinical decision support counts over 110 publications and 12 patents as of mid-2018. He has been principal investigator of research and development grants totaling $11 M from AHRQ, NIH, NSF and DOE. He founded Genomas and the Laboratory of Personalized Health in 2004. He has pioneered physiogenomics (U.S. Patent 7,747,392) based on multi-gene DNA markers and bioinformatics for the diagnosis of disease and prediction of human physiological responses to a wide array of clinical treatments (neuro-psychiatric and cardio-metabolic drugs, exercise, diet, surgery, hospitalization). Previously, he founded Genaissance Pharmaceuticals in 1997 as the pioneer company in pharmacogenomics, and served as Chief Executive and Chief Scientific Officer. Dr. Ruaño developed fundamental technology for genetic associations based on gene haplotypes. Dr. Ruaño invented the Coupled Amplification and Sequencing System (U.S. Patent 5,427,911) in 1992 for the rapid determination of sequence variation, licensed to TRUGENE™, the first FDA-approved pharmacogenomic diagnostic system. Dr. Ruaño was a founding Director of the Personalized Medicine Coalition in Washington, D.C. and senior editor of the journal Personalized Medicine (London). He has served on steering committees working with the FDA on pharmacogenomic guidelines and as a member at the Manhattan Institute's 21st Century FDA Task Force. Dr. Ruaño also served on advisory committees of the National Academy of Clinical Biochemistry instituting guidelines for pharmacogenetic testing in the clinical laboratory. Dr. Ruaño is also Director of Genetics Research at Hartford Hospital and Principal Investigator at the Institute of Living. He is a Fellow of the National Academy of Clinical Biochemistry and of the American Institute for Medical and Biological Engineering. He serves as a member of the Clinical Pharmacogenetics Implementation Consortium and the Pharmacogene Variation Consortium. Dr. Ruaño was elected to the Connecticut Academy of Science and Engineering in 2004. He was awarded the 2005 Medical Technology Award by the Biomedical Engineering Alliance of Connecticut for his contributions to personalized medicine and molecular diagnostics. He obtained his B.A. degree from Johns Hopkins University, where he was elected to Phi Betta Kappa. He obtained M.D. and Ph.D. degrees from Yale University, where he was a Fellow of the NIH Medical Scientist Training Program and the Ford Foundation. e is one of the 28 alumni in the University’s history honored in the Yale Innovation Timeline.

Mark Ferreira, B.A., Clinical Research Associate. Mr. Ferreira is Clinical Research Associate at the Genomas Laboratory of Personalized Health. Mr. Ferreira came to Genomas as an intern in 2017 after graduating from Trinity College in Hartford, Connecticut with a Bachelor of Arts degree in Biology with a concentration in Biomedical Science. While at Trinity, Mr. Ferreira was a member of the American Medical Student Association (AMSA), volunteered for the St. Baldrick’s Foundation, and received the prestigious Summit Scholarship for academic excellence. Mr. Ferreira also volunteered for and participated in many other organizations, one of which he co-founded with a Trinity faculty member. Mr. Ferreira is a two-time cancer survivor and overcame several medical hardships while at Trinity, which drives his passion for medicine but also gives him a unique perspective on clinical studies and patient care. Mr. Ferreira uses this dual-sided insight every day at Genomas to improve any and all aspects of the laboratory and the services it provides. Among other day-to-day operations, Mr. Ferreira processes all patient samples from start to finish, runs all assays offered by the Laboratory of Personalized Health, develops protocols, prepares the laboratory for inspections, compiles and analyzes data, and works on clinical research studies directly with the Medical Director and faculty at Hartford Hospital. As part of this research, Mr. Ferreira is now publishing with the Genomas team on various journals in the field of personalized medicine and genetics.

Copyright © 2019 Genomas, Inc. All Rights Reserved.